Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects
Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This is a phase 1, randomized, double-blind, placebo-controlled, 2-way crossover study to
evaluate the effect of AMG 151 on 24-hour ambulatory blood pressure and glucose levels in
subjects with type 2 diabetes mellitus who are on a stable regimen of metformin alone,
metformin and a dipeptidyl peptidase-4 inhibitor (DPP4), metformin and a thiazolidinedione
(TZD), or metformin, a DPP4, and a TZD for a minimum of 3 months prior to randomization.